Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16772211 | 0.86 | KDM4E (0.36) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL16420322 | 0.82 | KDM4E (0.47) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL16424290 | 0.76 | KDM4E (0.31) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL16769702 | 0.75 | KDM4E (0.41) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL16420329 | 0.75 | KDM4E (0.41) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL12092106 | 0.75 | ALDH1A1 (0.43) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL16421536 | 0.75 | ALDH1A1 (0.43) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL24398363 | 0.74 | GAA (0.44) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL16711487 | 0.74 | GAA (0.44) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL11941264 | 0.74 | GAA (0.44) | KDM4EALDH1A1GAAHPGDALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11233204-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-01-25 | — | — | US | disclosed |
| US-20190189938-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11233204-B2 | Organic electroluminescent materials and devices | LEF1, MLX, OCIAD1 | KDM4E 1840/4885ALDH1A1 742/4885GAA 3925/4885 |
| US-20190189938-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LEF1, MLX, OCIAD1 | KDM4E 1840/4885ALDH1A1 742/4885GAA 3925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.